By Luciano Martini (Eds.)
Read Online or Download Clinical Neuroendocrinology PDF
Best endocrinology & metabolism books
"Endocrinology and Metabolism" is a well-liked source overlaying uncomplicated rules and scientific administration of all-important endocrine and metabolic ailments. the focal point of this variation has been at the identity and elucidation of the most recent scientific findings in admire to the analysis and administration of endocrine illness.
Redux™ is a innovative new anti-obesity drug that has simply been authorized (July 1996) by way of the FDA. it's the first weight administration drug therapy to be introduced within the usa in two decades and isn't addictive, in contrast to prior medicinal drugs used for this goal. weight problems administration and Redux™ incorporates a short advent which leads as much as its discovery and comprises an outline of recent developments in weight problems administration.
New concepts in diabetes and its treatment
Diabetes mellitus and its issues are stipulations of becoming significance from either the scientific and epidemiological perspective. Diabetes has life-threatening issues affecting numerous organs and platforms, with elevated danger for ocular, renal, cardiac, cerebral, fearful and peripheral vascular affliction.
Actual task and weight problems, moment version, addresses an array of themes that discover and reveal the hyperlinks among actual task (or inactiveness) and weight problems. best scientists from numerous backgrounds workforce as much as offer an unmatched source reading the most recent examine and advancements within the box.
Additional resources for Clinical Neuroendocrinology
Example text
N. Engl. J. Med. 285, 1279-1283. , and Schally, A. V. (1970). Endocrinology 87, 653-657. , and Schally, A. V. (1971). Proc. Soc. Exp. BioL Med. 136, 290-293. , and Schally, A. V. (1976). Endocrinology 98, 1069-1072. , and Schally, A. V. (1971). Science 174, 511-512. , and Schally, A. V. (1972a). Endocrinology 91, 529-532. , and Schally, A. V. (1972b). Proc. Soc. Exp. Biol. Med. 140, 609-612. , Kastin, A. , and Schally, A. V. In "Gonadotropins" (B. B. Saxena, C. G. Beling, and H. M. ), pp. 32-48.
H. Coy, unpublished, 1976). VIII. , 1968, 1973a). , 1975) could be due to the presence of a GH-RF which under some conditions might predominate over inhibitory activity because of a short half-life of somatostatin. However, further work is needed for the isolation, determination of structure, and synthesis of the physiological GH-RF. This GH-RF might provide a useful therapeutic material for inducing normal growth in some pituitary dwarfs and perhaps capable of acting as an anabolic agent free of androgenic effects.
Wilber, J. , and Porter, J. C. (1970). Endocrinology 87, 807-811. Wilber, J. , and Seibel, M. J. (1973). Endocrinology 92, 888-893. 42 Andrew V. , and Utiger, R. D. (1974). Science 185, 265-267. , C. H. (1973). Biochem. Biophys. Res. Commun. 54, 882-887. Yen, S. S. C , Siler, T. , and DeVane, G. W. (1974a). N. Engl. J. Med. 290, 935-938. Yen, S. S. , and Siler, T. M. (1974b). J. Clin. Endocrinol. Metab. 39, 170-177. , Kastin, A. , and Schally, A. V. (1974). Fertil. Steril. 25, 160-169. , Rosner, J.
